Qing‐Ting Bu

489 total citations
19 papers, 357 citations indexed

About

Qing‐Ting Bu is a scholar working on Pharmacology, Molecular Biology and Biotechnology. According to data from OpenAlex, Qing‐Ting Bu has authored 19 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 15 papers in Molecular Biology and 7 papers in Biotechnology. Recurrent topics in Qing‐Ting Bu's work include Microbial Natural Products and Biosynthesis (19 papers), Genomics and Phylogenetic Studies (12 papers) and Microbial Metabolism and Applications (6 papers). Qing‐Ting Bu is often cited by papers focused on Microbial Natural Products and Biosynthesis (19 papers), Genomics and Phylogenetic Studies (12 papers) and Microbial Metabolism and Applications (6 papers). Qing‐Ting Bu collaborates with scholars based in China, Canada and Czechia. Qing‐Ting Bu's co-authors include Yong‐Quan Li, Pin Yu, Xu‐Ming Mao, Shuiping Liu, Zhenxing Zhou, Xin-Ai Chen, Jue Wang, Yi‐Ling Du, Penghui Yuan and Yueping Li and has published in prestigious journals such as Applied and Environmental Microbiology, Bioresource Technology and Applied Microbiology and Biotechnology.

In The Last Decade

Qing‐Ting Bu

19 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing‐Ting Bu China 11 279 257 102 70 45 19 357
Pin Yu China 10 288 1.0× 257 1.0× 97 1.0× 59 0.8× 54 1.2× 10 348
Lutz Petzke Germany 13 295 1.1× 303 1.2× 95 0.9× 44 0.6× 72 1.6× 16 416
Wendi A. Hale United States 3 332 1.2× 296 1.2× 101 1.0× 83 1.2× 51 1.1× 4 416
Shouliang Yin China 8 184 0.7× 241 0.9× 68 0.7× 45 0.6× 36 0.8× 12 346
Irene Santamarta Spain 14 357 1.3× 328 1.3× 65 0.6× 59 0.8× 85 1.9× 17 432
Oleksandr Yushchuk Ukraine 13 248 0.9× 255 1.0× 67 0.7× 65 0.9× 47 1.0× 33 367
Elisabeth Welle Germany 7 296 1.1× 329 1.3× 75 0.7× 49 0.7× 67 1.5× 8 407
Roy H. Mosher Canada 8 226 0.8× 250 1.0× 46 0.5× 72 1.0× 47 1.0× 11 351
Frank Wesche Germany 7 287 1.0× 335 1.3× 65 0.6× 60 0.9× 42 0.9× 13 450
Ines Böhm United Kingdom 9 318 1.1× 313 1.2× 78 0.8× 105 1.5× 66 1.5× 10 444

Countries citing papers authored by Qing‐Ting Bu

Since Specialization
Citations

This map shows the geographic impact of Qing‐Ting Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Ting Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Ting Bu more than expected).

Fields of papers citing papers by Qing‐Ting Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing‐Ting Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Ting Bu. The network helps show where Qing‐Ting Bu may publish in the future.

Co-authorship network of co-authors of Qing‐Ting Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Qing‐Ting Bu. A scholar is included among the top collaborators of Qing‐Ting Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing‐Ting Bu. Qing‐Ting Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bu, Qing‐Ting, et al.. (2024). Stepwise increase of fidaxomicin in an engineered heterologous host Streptomyces albus through multi-level metabolic engineering. Synthetic and Systems Biotechnology. 9(4). 766–774. 2 indexed citations
2.
Scharf, Daniel H., et al.. (2023). Degradation mechanism of AtrA mediated by ClpXP and its application in daptomycin production in Streptomyces roseosporus. Protein Science. 32(4). e4617–e4617. 3 indexed citations
3.
Bu, Qing‐Ting, et al.. (2023). Transcriptional regulation of the fidaxomicin gene cluster and cellular development in Actinoplanes deccanensis YP-1 by the pleiotropic regulator MtrA. Microbiology Spectrum. 11(6). e0270223–e0270223. 2 indexed citations
4.
Xu, Weifeng, et al.. (2022). A novel strategy of gene screen based on multi-omics in Streptomyces roseosporus. Applied Microbiology and Biotechnology. 106(8). 3103–3112. 7 indexed citations
5.
Bu, Qing‐Ting, Chenyang Zhu, Weifeng Xu, et al.. (2022). Improving the Yield and Quality of Daptomycin in Streptomyces roseosporus by Multilevel Metabolic Engineering. Frontiers in Microbiology. 13. 872397–872397. 18 indexed citations
6.
Xu, Weifeng, et al.. (2022). Degradation Mechanism of AAA+ Proteases and Regulation of Streptomyces Metabolism. Biomolecules. 12(12). 1848–1848. 6 indexed citations
7.
Li, Yueping, et al.. (2021). Genome-based rational engineering of Actinoplanes deccanensis for improving fidaxomicin production and genetic stability. Bioresource Technology. 330. 124982–124982. 16 indexed citations
8.
Bu, Qing‐Ting, et al.. (2021). Rational engineering strategies for achieving high-yield, high-quality and high-stability of natural product production in actinomycetes. Metabolic Engineering. 67. 198–215. 37 indexed citations
9.
Bu, Qing‐Ting, Yueping Li, Jue Wang, et al.. (2020). Comprehensive dissection of dispensable genomic regions in Streptomyces based on comparative analysis approach. Microbial Cell Factories. 19(1). 99–99. 14 indexed citations
10.
Bu, Qing‐Ting, Pin Yu, Jue Wang, et al.. (2019). Rational construction of genome-reduced and high-efficient industrial Streptomyces chassis based on multiple comparative genomic approaches. Microbial Cell Factories. 18(1). 16–16. 65 indexed citations
11.
Bu, Qing‐Ting, Jue Wang, Yu Liu, et al.. (2019). Activation of anthrachamycin biosynthesis in Streptomyces chattanoogensis L10 by site-directed mutagenesis of rpoB. Journal of Zhejiang University SCIENCE B. 20(12). 983–994. 10 indexed citations
12.
Li, Yueping, Pin Yu, Jifeng Li, et al.. (2019). FadR1, a pathway-specific activator of fidaxomicin biosynthesis in Actinoplanes deccanensis Yp-1. Applied Microbiology and Biotechnology. 103(18). 7583–7596. 12 indexed citations
14.
Wang, Kai, Xiaofang Liu, Qing‐Ting Bu, et al.. (2018). Transcriptome-Based Identification of a Strong Promoter for Hyper-production of Natamycin in Streptomyces. Current Microbiology. 76(1). 95–99. 9 indexed citations
15.
Liu, Shuiping, Penghui Yuan, Yueyue Wang, et al.. (2015). Generation of the natamycin analogs by gene engineering of natamycin biosynthetic genes in Streptomyces chattanoogensis L10. Microbiological Research. 173. 25–33. 30 indexed citations
16.
Liu, Shuiping, Pin Yu, Penghui Yuan, et al.. (2015). Sigma factor WhiGch positively regulates natamycin production in Streptomyces chattanoogensis L10. Applied Microbiology and Biotechnology. 99(6). 2715–2726. 28 indexed citations
17.
Zhou, Zhenxing, Qingqing Xu, Qing‐Ting Bu, et al.. (2014). Transcriptome-guided identification of SprA as a pleiotropic regulator in Streptomyces chattanoogensis. Applied Microbiology and Biotechnology. 99(3). 1287–1298. 9 indexed citations
18.
Zhou, Zhenxing, Qingqing Xu, Qing‐Ting Bu, et al.. (2014). Genome Mining‐Directed Activation of a Silent Angucycline Biosynthetic Gene Cluster in Streptomyces chattanoogensis. ChemBioChem. 16(3). 496–502. 42 indexed citations
19.
Yu, Pin, Shuiping Liu, Qing‐Ting Bu, et al.. (2014). WblAch, a Pivotal Activator of Natamycin Biosynthesis and Morphological Differentiation in Streptomyces chattanoogensis L10, Is Positively Regulated by AdpAch. Applied and Environmental Microbiology. 80(22). 6879–6887. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026